X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Molecular Oncology

期刊標題檢索 MOL ONCOL 最新評論: It is suggested to be cautious about investing in this magazine, it is... (2024-09-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Molecular Oncology]您好,您是該頁面的第 32755 位訪客。

期刊簡介
期刊名稱Molecular Oncology Molecular Oncology
LetPub Score
7.3
50 ratings
Rate

Reputation
8.3

Influence
6.6

Speed
7.0

期刊簡稱MOL ONCOL
ISSN1878-0261
h-index63
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.601.9401.168
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q126 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q143 / 404
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q125 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q136 / 230

自引率 (2023-2024)2.00%自引率趨勢
掲載範囲
Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles.

The journal is now fully Open Access with all articles published over the past 10 years freely available.
官方網站https://www.sciencedirect.com/journal/molecular-oncology
在線稿件提交
開放訪問Yes
出版商John Wiley and Sons Ltd
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區Netherlands
發行頻率
創刊年0
每年文章數172每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( USD3910; GBP2620; EUR3550; )
APC waiver:Check Notes
Other charges: No
Keywords: cancer、molecular biology、molecular genetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ167/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1878-0261%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 10 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Molecular Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal for ImmunoTherapy of CancerH-index: 36

    CiteScore: 17.70
    Biomarker ResearchH-index: 0

    CiteScore: 15.80
    Cell Chemical BiologyH-index: 166

    CiteScore: 14.70
    Molecular BiomedicineH-index: 0

    CiteScore: 6.30
    VIROLOGICA SINICAH-index: 20

    CiteScore: 9.30
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 0

    CiteScore: 11.50
    Biotechnology JournalH-index: 70

    CiteScore: 8.90
    Frontiers in GeneticsH-index: 61

    CiteScore: 5.50
    Pharmacogenomics & Personalized MedicineH-index: 0

    CiteScore: 3.30
    Advances in Biological RegulationH-index: 0

    CiteScore: 8.90
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics334768
    Cell Chemical Biology78305
    Journal for ImmunoTherapy of Cancer77342
    Biotechnology Journal44195
    VIROLOGICA SINICA41051
    Biomarker Research37509
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE17092
    Pharmacogenomics & Personalized Medicine15172
    Molecular Biomedicine7109
    Exploration of Medicine4119
  •  

    Molecular Oncology Molecular Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/9)
  [Molecular Oncology] 的評論撰寫評論
作者: 冰春mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-14 16:39:48 評論於
It is suggested to be cautious about investing in this magazine, it is best to boycott this garbage magazine! It is a very trashy magazine! After external review for 3 months, make revisions and conduct additional experiments according to the reviewers' opinions before resubmitting. Two months later, after the second review, make further revisions and resubmit. Suddenly rejected 20 days later, without providing any reasons based on the reviewers' opinions. The whole process took nearly 7 months.
(0) 讚! | 冰春mm

作者: 冰春mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-12 19:15:50 評論於
Yes, this magazine is quite rubbish. I submitted an article, which took half a year and underwent two major revisions. The reviewers had no comments and even said "very nice." However, the editorial department rejected it, saying the images did not meet the standards. Why didn't they say so earlier? This is clearly a scam! I suggest boycotting this rubbish journal!!!
(0) 讚! | 冰春mm

作者: 仲夏美媛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 17:56:15 評論於
It's been 4 days, still in initial check
(0) 讚! | 仲夏美媛

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 20:39:56 評論於
He vetoed it, saying that the original picture you provided did not meet the requirements
(0) 讚! | 墟散云泽

作者: 风啸香薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-13 16:06:27 評論於
Is there any association with the magazine? I also encountered this problem
(0) 讚! | 风啸香薇

作者: 多罗浩迪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-11 08:27:10 評論於
Submission acceptance rate: 50.0
Research focus: Tumor
Experience: Submitted a review article in mid-August 2023, received a Major Revision after one and a half months, accepted after two months of revisions, and took a total of 4 months. Overall, the journal's review level is relatively high, the reviewers are very professional, the requirements are strict, and the review speed is very fast. I would like to ask how long it will take for this journal to be indexed by WOS after being online?
(0) 讚! | 多罗浩迪

作者: 凌霄天空


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 23:23:09 評論於
There is none
(0) 讚! | 凌霄天空

作者: 凌霄天空


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 20:26:28 評論於
No requirements
(0) 讚! | 凌霄天空

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-21 14:53:15 評論於
After completing the experiment and undergoing a second review, the materials are submitted
(0) 讚! | 墟散云泽

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-21 12:39:11 評論於
Complete the experiment, submit all original materials after the second review
(0) 讚! | 墟散云泽

作者: 风啸香薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-20 17:44:27 評論於
Do you receive and then provide original data? My minor edits also require original data
(0) 讚! | 风啸香薇

作者: 风啸香薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-20 10:13:56 評論於
Are you asking for the original data?
(0) 讚! | 风啸香薇

作者: 风啸香薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-20 08:54:05 評論於
Is it because of the original data or the problem of the pictures during the supplementary experiment that the article was rejected?
(0) 讚! | 风啸香薇

作者: 凌霄天空


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-13 18:19:34 評論於
Two major revisions, oh no, I thought there was no hope, but the reviewer unexpectedly let it go, I want to thank him so much
(0) 讚! | 凌霄天空

作者: 凌霄天空


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-13 10:30:39 評論於
2023.5.15 Submitted
2023.5.15 Intial check
2023.5.15 Awiting AE assignment
2023.5.17 Under review
2023.7.17 Major Revision (Due on 9.15)
2023.9.15 Revision submitted
2023.9.15 Initial check
2023.9.18 Under review
2023.10.10 Major Revision (Due on 12.9)
2023.11.17 Revision submitted
2023.11.17 Initial check
2023.11.22 Under review
2023.12.13 Accept
(0) 讚! | 凌霄天空

作者: 半月小蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-22 10:01:16 評論於
Have you voted?
(0) 讚! | 半月小蕊

作者: 白云紫萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-27 10:42:47 評論於
How long does the external audit take? It has been one month since the external audit began. How much longer will it take to finish?
(0) 讚! | 白云紫萍

作者: 犬走千风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-18 20:53:49 評論於
It has been suggested to transfer
(0) 讚! | 犬走千风

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 16:37:43 評論於
The article is under review
(0) 讚! | Darlene Pepys

作者: 犬走千风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 14:51:48 評論於
One day has undergone review, what is going on? Is it being sent for external review? Or is it still under internal review?
(0) 讚! | 犬走千风

作者: 犬走千风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 14:16:43 評論於
Am I in the reviewing state as well? Or is it an internal audit?
(0) 讚! | 犬走千风

作者: 犬走千风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 09:28:01 評論於
Can I know how long it will take for this magazine awaiting AE assignment?
(0) 讚! | 犬走千风

作者: 犬走千风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-14 09:13:06 評論於
I would like to ask how long it will take for this magazine "awaiting AE assignment" to be ready?
(0) 讚! | 犬走千风

作者: 宗室平乐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-07 19:01:51 評論於
Hello, how do I submit the original images for WB? Do all images need to be marked with lanes? What could be the reason for rejection by the editor? Thank you!
(0) 讚! | 宗室平乐

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-07 15:28:18 評論於
It's not a lane marker, it's a whole sheet of film with markers on it
(0) 讚! | 墟散云泽

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/9)

開始撰寫 [Molecular Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*